Endius

About Endius

Endius, Inc. operated as a developer and manufacturer of medical devices focused on the minimally invasive spine surgery market. Founded in 1992, the company pioneered the development of products, implants, and techniques designed to treat spine diseases with less trauma to the patient. Before its acquisition, the firm was based in Plainville, Massachusetts, and had grown to approximately 43 employees primarily engaged in product development, marketing, and operations. The company's business model revolved around the design, manufacturing, and sale of specialized surgical systems to healthcare providers. Endius's product portfolio was centered on enabling surgeons to perform complex spinal procedures through minimally invasive methods. A key offering was the Atavi® Atraumatic Spine Surgery System, which integrated access technology, visualization, and instrumentation to allow for a range of lumbar spine fusion procedures through small incisions. Other significant products included the TiTLE® 2 Pedicle Screw System, the Minit™ Upper Thoracic Fixation and Posterior Cervical System, and the NorthStar™ Cannulated Screw Delivery System, all designed for both minimally invasive and traditional open surgeries. A notable feature of its product line was the FlexPosure® Retractor for lumbar applications and the NexPosure™ MIS Access for the posterior cervical spine, which provided surgeons with an integrated system for a variety of fusion procedures. Endius successfully navigated several rounds of venture capital funding, raising a total of $48.8 million from investors such as The Carlyle Group, EGS Healthcare Capital Partners, and Morgan Stanley. This financial backing supported the company through its research and development phase into commercialization. The company's trajectory culminated in its acquisition by Zimmer Holdings, Inc. (now Zimmer Biomet) in a cash transaction announced in February 2007 and completed in the second quarter of that year. The acquisition was a strategic move by Zimmer to bolster its position in the growing market for minimally invasive spinal technologies.